Pain Treatment Center – High Profits

Description

Regenerative medicine franchise for sale offering cash-pay, non-surgical treatment programs for patients with joint, muscle, tendon, ligament and other musculoskeletal complaints. The business operates without insurance billing and includes rights to a protected multi-unit territory, subject to the franchise agreement.

Services

• Platelet-rich plasma (PRP)
• Plasma-based treatments
• A2M therapies
• Class IV laser therapy
• Bone marrow-derived procedures
• Other regenerative or injection-based services offered within the franchise system

The listing also references amniotic membrane and stem-cell-related treatments. Buyers should independently confirm which products and procedures are currently permitted, how they are marketed, and whether they comply with applicable federal and state requirements.

Business model

The clinic operates on a private-pay basis and does not currently accept insurance. Treatment plans are sold directly to patients rather than reimbursed through commercial payers.

Team

• Front desk representative
• CMA/phlebotomist
• PA or NP
• Office manager

The current model does not require the owner to provide clinical care personally. A buyer with a management background may be able to oversee the business while licensed clinicians provide treatment.

Ownership options

The franchisor also represents that a passive ownership structure may be available through its management company. Buyers should review the management agreement separately, including fees, control rights, staffing responsibilities and termination provisions.

Territory

The opportunity includes a protected multi-unit territory. Buyers should confirm the exact geography, development schedule, minimum opening requirements and any deadlines tied to retaining those rights.

Buyer review

Buyers should verify historical financials, patient volume, average treatment value, marketing costs, clinician compensation, equipment ownership, consumable costs, lease terms and franchise fees.

Healthcare ownership rules, professional licensing, prescribing authority, medical supervision and corporate-practice-of-medicine restrictions should also be reviewed for the applicable state.

Regenerative medicine products and procedures involving stem cells, amniotic tissue, bone marrow or similar biologic materials may be subject to FDA regulation and should not be assumed to be approved for every advertised use. Buyers should review product sourcing, labeling, clinical protocols, informed-consent materials and marketing claims with qualified healthcare counsel before closing.